AiDEX mg/dL
AiDEX mg/dL Summary
AiDEX mg/dL is a mobile iOS app in Medical by Micro Tech Medical (Hangzhou) Co., LTD.. Released in Dec 2021 (4 years ago). It has 21 ratings with a 2.67★ (poor) average. Based on AppGoblin estimates, it reaches roughly 86 monthly active users . Store metadata: updated Dec 25, 2024.
Data tracking: SDKs and third-party integrations were last analyzed on Feb 13, 2025.
Store info: Last updated on App Store on Dec 25, 2024 .
2.67★
Ratings: 21
Screenshots
App Description
The AiDEX App can be used with the AiDEX Continuous Glucose Monitoring System. The AiDEX App allows you to monitor your glucose with your phone. You could calibrate your glucose value after 6 hour your Sensor being inserted successfully. The AiDEX App is compatible with 7/10/14 days Sensors. You can use the AiDEX App to:
•Check your glucose value every 5 mintutes, instead of a routine fingerstick.*
•View your current glucose reading, trend arrow, and history.
•Add notes to track your food, insulin use,medicine and exercise.
•See glucose reports, including your Ambulatory Glucose Profile.
•Connect to healthcare professionals with Pancares.**
*Fingersticks are required if your glucose alarms and readings do not match symptoms. **For a list of compatible devices, please visit http://www.microtechmd.com/en/support/More-support
The AiDEX Continuous Glucose Monitoring System (CGMS) is indicated for continuous or regular monitoring of glucose levels in subcutaneous tissue, and is used for daily detection and self-management of blood glucose levels in people age 14 years and older. It is intended for use by patients at home and in healthcare facilities.
Interpretation of the AiDEX CGMS results should be based on the glucose trends and several sequential readings over time. The AiDEX CGMS also aids in the detection of episodes of hyperglycemia and hypoglycemia. Measurements should not be used to make treatment adjustments, but rather as a reminder of when fingertip testing is required. It cannot be used for the diagnosis and screening of diabetes, nor as a basis for drug therapy decisions.
【CONTACT】
Email: bin.ni@microtechmd.com